{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:45Z","timestamp":1792784265998,"version":"4.5.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Harbin Medical University, China","award":["YJSCX2023-283HYD"],"award-info":[{"award-number":["YJSCX2023-283HYD"]}],"id":[{"id":"https:\/\/ror.org\/05jscf583","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hong Kong Scholars Program, China","award":["XJ2020012"],"award-info":[{"award-number":["XJ2020012"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"crossref","award":["82472743 and 82300921"],"award-info":[{"award-number":["82472743 and 82300921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"crossref","award":["82102911"],"award-info":[{"award-number":["82102911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The matic Research Support Scheme of State Key Laboratory of Liver Research, The University of Hong Kong, China","award":["SKLLR\/TRSS\/2022\/08"],"award-info":[{"award-number":["SKLLR\/TRSS\/2022\/08"]}],"id":[{"id":"https:\/\/ror.org\/02zhqgq86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Heilongjiang Province, China","award":["PL2024H154"],"award-info":[{"award-number":["PL2024H154"]}]},{"name":"the Horizontal Project of Harbin Medical University, China","id":[{"id":"https:\/\/ror.org\/05jscf583","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Excellent Youth Project of Natural Science Foundation of Heilongjiang Province, China","award":["YQ2022H011"],"award-info":[{"award-number":["YQ2022H011"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation, China","doi-asserted-by":"crossref","award":["2021M693823"],"award-info":[{"award-number":["2021M693823"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Excellent Youth Project of the Fourth Affiliated Hospital of Harbin Medical University, China","award":["HYDSYYXQN202102 and HYDSYYXQN202301"],"award-info":[{"award-number":["HYDSYYXQN202102 and HYDSYYXQN202301"]}],"id":[{"id":"https:\/\/ror.org\/02s7c9e98","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Provincial Universities, China","award":["2021-KYYWF-0259"],"award-info":[{"award-number":["2021-KYYWF-0259"]}]},{"name":"Heilongjiang Postdoctoral Science Foundation, China","award":["LBH-Z20180"],"award-info":[{"award-number":["LBH-Z20180"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03018-3","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:47:34Z","timestamp":1756457254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The diverse roles of circular RNAs in cholangiocarcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Yanhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-4798","authenticated-orcid":false,"given":"Gang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-3801","authenticated-orcid":false,"given":"Daolin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"3018_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","journal-title":"Cancer Genet"},{"issue":"9","key":"3018_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3018_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72(1):95\u2013103. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.007.","journal-title":"J Hepatol"},{"key":"3018_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CMAR.S344711","volume":"14","author":"H Zhao","year":"2022","unstructured":"Zhao H, Lu B. Prediction of multiple serum tumor markers in hepatolithiasis complicated with intrahepatic cholangiocarcinoma. Cancer Manag Res. 2022;14:249\u201355. https:\/\/doi.org\/10.2147\/CMAR.S344711.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3018_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3018_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2017.03.026","volume":"67","author":"SI Ilyas","year":"2017","unstructured":"Ilyas SI, Gores GJ. Emerging molecular therapeutic targets for cholangiocarcinoma. J Hepatol. 2017;67(3):632\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.026.","journal-title":"J Hepatol"},{"key":"3018_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.canlet.2017.11.022","volume":"414","author":"S Qu","year":"2018","unstructured":"Qu S, Liu Z, Yang X, et al. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2018;414:301\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2017.11.022.","journal-title":"Cancer Lett"},{"issue":"11","key":"3018_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrg.2016.114","volume":"17","author":"L Szabo","year":"2016","unstructured":"Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17(11):679\u201392. https:\/\/doi.org\/10.1038\/nrg.2016.114.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"3018_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475\u201390. https:\/\/doi.org\/10.1038\/s41580-020-0243-y.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"3018_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/ijbs.22531","volume":"13","author":"M Wang","year":"2017","unstructured":"Wang M, Yu F, Wu W, et al. Circular RNAs: a novel type of non-coding RNA and their potential implications in antiviral immunity. Int J Biol Sci. 2017;13(12):1497\u2013506. https:\/\/doi.org\/10.7150\/ijbs.22531.","journal-title":"Int J Biol Sci"},{"issue":"21","key":"3018_CR11","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1042\/CS20190940","volume":"133","author":"C Louis","year":"2019","unstructured":"Louis C, Desoteux M, Coulouarn C. Exosomal circRNAs: new players in the field of cholangiocarcinoma. Clin Sci (Lond). 2019;133(21):2239\u201344. https:\/\/doi.org\/10.1042\/CS20190940.","journal-title":"Clin Sci (Lond)"},{"key":"3018_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","volume":"187","author":"B Han","year":"2018","unstructured":"Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31\u201344. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.010.","journal-title":"Pharmacol Ther"},{"key":"3018_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-018-0935-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway. Mol Cancer. 2019;18:20. https:\/\/doi.org\/10.1186\/s12943-018-0935-5.","journal-title":"Mol Cancer"},{"issue":"18","key":"3018_CR14","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.7150\/thno.44419","volume":"10","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang H, Yang Y, et al. Hypoxia induced exosomal circRNA promotes metastasis of colorectal cancer via targeting GEF-H1\/RhoA axis. Theranostics. 2020;10(18):8211\u201326. https:\/\/doi.org\/10.7150\/thno.44419.","journal-title":"Theranostics"},{"key":"3018_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu J, Ji L, Liang Y, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020;5:298. https:\/\/doi.org\/10.1038\/s41392-020-00375-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"3018_CR16","doi-asserted-by":"publisher","first-page":"13338","DOI":"10.18632\/aging.103438","volume":"12","author":"P Zhou","year":"2020","unstructured":"Zhou P, Xie W, Huang HL, et al. CircRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1\u03b1 pathway. Aging (Albany NY). 2020;12(13):13338\u201353. https:\/\/doi.org\/10.18632\/aging.103438.","journal-title":"Aging (Albany NY)"},{"key":"3018_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-021-01481-w","volume":"21","author":"CH Wong","year":"2022","unstructured":"Wong CH, Lou UK, Fung FKC, et al. Circrtn4 promotes pancreatic cancer progression through a novel circrna-miRNA-lncrna pathway and stabilizing epithelial-mesenchymal transition protein. Mol Cancer. 2022;21:10. https:\/\/doi.org\/10.1186\/s12943-021-01481-w.","journal-title":"Mol Cancer"},{"issue":"1","key":"3018_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","volume":"76","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wang H, Li Z, et al. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol. 2022;76(1):135\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.027.","journal-title":"J Hepatol"},{"issue":"2","key":"3018_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger PJ. Different strategies for cancer treatment: Targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.02.12.","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"3018_CR20","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/hep.32232","volume":"75","author":"H Li","year":"2022","unstructured":"Li H, Lan T, Liu H, et al. IL-6\u2013induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma. Hepatology. 2022;75(6):1402\u201319. https:\/\/doi.org\/10.1002\/hep.32232.","journal-title":"Hepatology"},{"issue":"4","key":"3018_CR21","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/hep.31493","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, Leng K, Yao Y, et al. A circular RNA, cholangiocarcinoma-associated circular RNA 1, contributes to cholangiocarcinoma progression, induces angiogenesis, and disrupts vascular endothelial barriers. Hepatology. 2021;73(4):1419\u201335. https:\/\/doi.org\/10.1002\/hep.31493.","journal-title":"Hepatology"},{"issue":"1","key":"3018_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41419-022-04534-0","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Chen Z, Li Z, et al. Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256. Cell Death Dis. 2022;13(1):94. https:\/\/doi.org\/10.1038\/s41419-022-04534-0.","journal-title":"Cell Death Dis"},{"issue":"23","key":"3018_CR23","doi-asserted-by":"publisher","first-page":"25195","DOI":"10.18632\/aging.203735","volume":"13","author":"C Guan","year":"2021","unstructured":"Guan C, Liu L, Zhao Y, et al. YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1. Aging (Albany NY). 2021;13(23):25195\u2013212. https:\/\/doi.org\/10.18632\/aging.203735.","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"3018_CR24","doi-asserted-by":"publisher","first-page":"e00042","DOI":"10.1128\/MCB.00042-20","volume":"40","author":"D Li","year":"2020","unstructured":"Li D, Tang Z, Gao Z, Shen P, Liu Z, Dang X. Circular RNA CDR1as exerts oncogenic properties partially through regulating microRNA 641 in cholangiocarcinoma. Mol Cell Biol. 2020;40(15):e00042-e120. https:\/\/doi.org\/10.1128\/MCB.00042-20.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"3018_CR25","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/jcmm.16392","volume":"25","author":"Y Xu","year":"2021","unstructured":"Xu Y, Gao P, Wang Z, et al. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation. J Cell Mol Med. 2021;25(7):3226\u201338. https:\/\/doi.org\/10.1111\/jcmm.16392.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"3018_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.18632\/aging.101872","volume":"11","author":"Y Xu","year":"2019","unstructured":"Xu Y, Yao Y, Liu Y, et al. Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma. Aging (Albany NY). 2019;11(7):1907\u201317. https:\/\/doi.org\/10.18632\/aging.101872.","journal-title":"Aging (Albany NY)"},{"key":"3018_CR27","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2147\/OTT.S289241","volume":"14","author":"Y Su","year":"2021","unstructured":"Su Y, Yu T, Wang Y, Huang X, Wei X. Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2. Onco Targets Ther. 2021;14:1117\u201329. https:\/\/doi.org\/10.2147\/OTT.S289241.","journal-title":"Onco Targets Ther"},{"issue":"22","key":"3018_CR28","doi-asserted-by":"publisher","first-page":"23251","DOI":"10.18632\/aging.104099","volume":"12","author":"X Zhao","year":"2020","unstructured":"Zhao X, Zhang X, Zhang Z, et al. Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma. Aging (Albany NY). 2020;12(22):23251\u201374. https:\/\/doi.org\/10.18632\/aging.104099.","journal-title":"Aging (Albany NY)"},{"key":"3018_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13046-021-02095-2","volume":"40","author":"YP Xu","year":"2021","unstructured":"Xu YP, Dong ZN, Wang SW, et al. Circhmgcs1\u2013016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res. 2021;40:290. https:\/\/doi.org\/10.1186\/s13046-021-02095-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3018_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbrc.2018.01.077","volume":"496","author":"Y Xu","year":"2018","unstructured":"Xu Y, Yao Y, Zhong X, et al. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Biochem Biophys Res Commun. 2018;496(2):455\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.077.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3018_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23138","volume":"34","author":"Q Lu","year":"2019","unstructured":"Lu Q, Fang T. Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma. J Clin Lab Anal. 2019;34(4): e23138. https:\/\/doi.org\/10.1002\/jcla.23138.","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"3018_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/CAD.0000000000001487","volume":"34","author":"G Wang","year":"2023","unstructured":"Wang G, Gao X, Sun Z, et al. Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p\/tumor necrosis factor receptor associated factor 3 axis. Anticancer Drugs. 2023;34(9):1002\u20139. https:\/\/doi.org\/10.1097\/CAD.0000000000001487.","journal-title":"Anticancer Drugs"},{"key":"3018_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153901","volume":"234","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhao Y, Wang W, et al. Upregulation of circ_0059961 suppresses cholangiocarcinoma development by modulating miR-629-5p\/SFRP2 axis. Pathol-Res Pract. 2022;234: 153901. https:\/\/doi.org\/10.1016\/j.prp.2022.153901.","journal-title":"Pathol-Res Pract"},{"issue":"18","key":"3018_CR34","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1042\/CS20190589","volume":"133","author":"S Wang","year":"2019","unstructured":"Wang S, Hu Y, Lv X, et al. Circ-0000284 arouses malignant phenotype of cholangiocarcinoma cells and regulates the biological functions of peripheral cells through cellular communication. Clin Sci. 2019;133(18):1935\u201353. https:\/\/doi.org\/10.1042\/CS20190589.","journal-title":"Clin Sci"},{"issue":"10","key":"3018_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.14670\/HH-18-544","volume":"38","author":"J Sun","year":"2023","unstructured":"Sun J, Feng M, Zou H, Mao Y, Yu W. Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression. Histol Histopathol. 2023;38(10):1129\u201343. https:\/\/doi.org\/10.14670\/HH-18-544.","journal-title":"Histol Histopathol"},{"key":"3018_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153732","volume":"230","author":"J Tang","year":"2022","unstructured":"Tang J, Wang R, Tang R, Gu P, Han J, Huang W. Circrtn4ip1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production. Pathology. 2022;230: 153732. https:\/\/doi.org\/10.1016\/j.prp.2021.153732.","journal-title":"Pathology"},{"issue":"4","key":"3018_CR37","doi-asserted-by":"publisher","first-page":"10191","DOI":"10.1080\/21655979.2022.2061283","volume":"13","author":"W Xiong","year":"2022","unstructured":"Xiong W, Zhang A, Xiao X, Liu W. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microrna-421 expression. Bioengineered. 2022;13(4):10191\u2013201. https:\/\/doi.org\/10.1080\/21655979.2022.2061283.","journal-title":"Bioengineered"},{"key":"3018_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-021-01482-9","volume":"21","author":"J Du","year":"2022","unstructured":"Du J, Lan T, Liao H, et al. Circnfib inhibits tumor growth and metastasis through suppressing MEK1\/ERK signaling in intrahepatic cholangiocarcinoma. Mol Cancer. 2022;21:18. https:\/\/doi.org\/10.1186\/s12943-021-01482-9.","journal-title":"Mol Cancer"},{"key":"3018_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbrc.2022.02.073","volume":"600","author":"F Xiao","year":"2022","unstructured":"Xiao F, Xu F, Zhang H, Shuai X. Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4\/MyD88\/IL6 axis. Biochem Biophys Res Commun. 2022;600:101\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.073.","journal-title":"Biochem Biophys Res Commun"},{"key":"3018_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.653207","volume":"9","author":"J Tu","year":"2021","unstructured":"Tu J, Chen W, Zheng L, et al. Circular RNA circ0021205 promotes cholangiocarcinoma progression through miR-204-5p\/RAB22A axis. Front Cell Dev Biol. 2021;9: 653207. https:\/\/doi.org\/10.3389\/fcell.2021.653207.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3018_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-022-05540-y","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu X, Tong H, Chen J, et al. Circrna mboat2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mrna cytoplasmic export. Cell Death Dis. 2023;14(1):20. https:\/\/doi.org\/10.1038\/s41419-022-05540-y.","journal-title":"Cell Death Dis"},{"key":"3018_CR42","doi-asserted-by":"publisher","first-page":"960327122112649","DOI":"10.1177\/09603271221126494","volume":"41","author":"J Tang","year":"2022","unstructured":"Tang J, Tang R, Gu P, Han J, Huang W, Xue F. Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340-5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma. Hum Exp Toxicol. 2022;41:9603271221126494. https:\/\/doi.org\/10.1177\/09603271221126494.","journal-title":"Hum Exp Toxicol"},{"issue":"32","key":"3018_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303814","volume":"10","author":"ZW Chen","year":"2023","unstructured":"Chen ZW, Kang FP, Xie CK, et al. A novel trojan horse nanotherapy strategy targeting the cPKM-STMN1\/TGFB1 axis for effective treatment of intrahepatic cholangiocarcinoma. Adv Sci (Weinh). 2023;10(32): e2303814. https:\/\/doi.org\/10.1002\/advs.202303814.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3018_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-023-02699-w","volume":"42","author":"W Liao","year":"2023","unstructured":"Liao W, Du J, Li L, et al. CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN\/AKT pathway in intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res. 2023;42(1):125. https:\/\/doi.org\/10.1186\/s13046-023-02699-w.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"3018_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100900","volume":"5","author":"C Louis","year":"2023","unstructured":"Louis C, Ferlier T, Leroux R, et al. TGF\u03b2-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p. JHEP Rep. 2023;5(12): 100900. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100900.","journal-title":"JHEP Rep"},{"issue":"1","key":"3018_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13046-023-02813-y","volume":"42","author":"J Zheng","year":"2023","unstructured":"Zheng J, Wang Y, Tao L, et al. Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation. J Exp Clin Cancer Res. 2023;42(1):239. https:\/\/doi.org\/10.1186\/s13046-023-02813-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3018_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.gendis.2022.05.005","volume":"10","author":"X Zhong","year":"2023","unstructured":"Zhong X, Ji C, Ren D, Ke A, Yang Z. Circular RNA circeif3c promotes intrahepatic cholangiocarcinoma progression and immune evasion via the miR-34a-5p\/B7-H4 axis. Genes Dis. 2023;10(2):370\u20132. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.005.","journal-title":"Genes Dis"},{"issue":"38","key":"3018_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402329","volume":"11","author":"RX Chen","year":"2024","unstructured":"Chen RX, Liu SC, Kan XC, et al. Circugp2 suppresses intrahepatic cholangiocarcinoma progression via p53 signaling through interacting with PURB to regulate ADGRB1 transcription and sponging miR-3191-5p. Adv Sci. 2024;11(38): e2402329. https:\/\/doi.org\/10.1002\/advs.202402329.","journal-title":"Adv Sci"},{"issue":"1","key":"3018_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-024-03006-x","volume":"43","author":"J Li","year":"2024","unstructured":"Li J, Xu X, Xu K, et al. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1. J Exp Clin Cancer Res. 2024;43(1):119. https:\/\/doi.org\/10.1186\/s13046-024-03006-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3018_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12943-024-01950-y","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Wang Y, Wang T, et al. CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinoma. Mol Cancer. 2024;23(1):35. https:\/\/doi.org\/10.1186\/s12943-024-01950-y.","journal-title":"Mol Cancer"},{"issue":"10","key":"3018_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409173","volume":"12","author":"C Guan","year":"2025","unstructured":"Guan C, Gao J, Zou X, et al. A novel 167-amino acid protein encoded by CircPCSK6 inhibits intrahepatic cholangiocarcinoma progression via IKB\u03b1 ubiquitination. Adv Sci. 2025;12(10): 2409173. https:\/\/doi.org\/10.1002\/advs.202409173.","journal-title":"Adv Sci"},{"issue":"2","key":"3018_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030733","volume":"7","author":"J Salzman","year":"2012","unstructured":"Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular rNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE. 2012;7(2): e30733. https:\/\/doi.org\/10.1371\/journal.pone.0030733.","journal-title":"PLoS ONE"},{"issue":"1","key":"3018_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert LFR, MacRae IJ. Regulation of microrna function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0045-7.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3018_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12935-020-01390-w","volume":"20","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zheng R, Chen J, Ning D. CircRNA CDR1as\/miR-641\/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC). Cancer Cell Int. 2020;20:289. https:\/\/doi.org\/10.1186\/s12935-020-01390-w.","journal-title":"Cancer Cell Int"},{"key":"3018_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-021-01894-x","volume":"40","author":"X Zhou","year":"2021","unstructured":"Zhou X, Liu K, Cui J, et al. Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p\/GOT1 axis in pancreatic cancer. J Exp Clin Cancer Res. 2021;40:124. https:\/\/doi.org\/10.1186\/s13046-021-01894-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"3018_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.565","volume":"11","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang L, Sun Q, et al. Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR-576-5p\/PCDH10 axis. Clin Transl Med. 2021;11(11): e565. https:\/\/doi.org\/10.1002\/ctm2.565.","journal-title":"Clin Transl Med"},{"issue":"17","key":"3018_CR57","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1080\/15384101.2020.1806449","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zheng F, Wang Z, Lu J, Zhang H. Circular RNA circ-SLC7A6 acts as a tumor suppressor in non-small cell lung cancer through abundantly sponging miR-21. Cell Cycle. 2020;19(17):2235\u201346. https:\/\/doi.org\/10.1080\/15384101.2020.1806449.","journal-title":"Cell Cycle"},{"issue":"2","key":"3018_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41419-018-1287-1","volume":"10","author":"Z Liu","year":"2019","unstructured":"Liu Z, Zhou Y, Liang G, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10(2):55. https:\/\/doi.org\/10.1038\/s41419-018-1287-1.","journal-title":"Cell Death Dis"},{"key":"3018_CR59","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.omtn.2020.06.002","volume":"21","author":"B Xia","year":"2020","unstructured":"Xia B, Zhao Z, Wu Y, Wang Y, Zhao Y, Wang J. Circular RNA circTNPO3 regulates paclitaxel resistance of ovarian cancer cells by miR-1299\/NEK2 signaling pathway. Mol Ther Nucleic Acids. 2020;21:780\u201391. https:\/\/doi.org\/10.1016\/j.omtn.2020.06.002.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3018_CR60","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19:30. https:\/\/doi.org\/10.1186\/s12943-020-1135-7.","journal-title":"Mol Cancer"},{"issue":"10","key":"3018_CR61","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jmcb\/mjz091","volume":"11","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang Z. IRES-mediated cap-independent translation, a path leading to hidden proteome. J Mol Cell Biol. 2019;11(10):911\u20139. https:\/\/doi.org\/10.1093\/jmcb\/mjz091.","journal-title":"J Mol Cell Biol"},{"issue":"3","key":"3018_CR62","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206. https:\/\/doi.org\/10.1038\/s41571-021-00585-y.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3018_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/cdd.2016.133","volume":"24","author":"WW Du","year":"2017","unstructured":"Du WW, Fang L, Yang W, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24(2):357\u201370. https:\/\/doi.org\/10.1038\/cdd.2016.133.","journal-title":"Cell Death Differ"},{"issue":"36","key":"3018_CR64","doi-asserted-by":"publisher","first-page":"58331","DOI":"10.18632\/oncotarget.11110","volume":"7","author":"L Lobos-Gonz\u00e1lez","year":"2016","unstructured":"Lobos-Gonz\u00e1lez L, Silva V, Araya M, et al. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors. Oncotarget. 2016;7(36):58331\u201350. https:\/\/doi.org\/10.18632\/oncotarget.11110.","journal-title":"Oncotarget"},{"key":"3018_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-019-1120-1","volume":"19","author":"J He","year":"2020","unstructured":"He J, Huang Z, He M, et al. Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas. Mol Cancer. 2020;19:17. https:\/\/doi.org\/10.1186\/s12943-019-1120-1.","journal-title":"Mol Cancer"},{"issue":"3","key":"3018_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41571-018-0134-8","volume":"16","author":"RL Anderson","year":"2019","unstructured":"Anderson RL, Balasas T, Callaghan J, et al. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 2019;16(3):185\u2013204. https:\/\/doi.org\/10.1038\/s41571-018-0134-8.","journal-title":"Nat Rev Clin Oncol"},{"key":"3018_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.553706","volume":"11","author":"S Jiang","year":"2021","unstructured":"Jiang S, Fu R, Shi J, et al. CircRNA-mediated regulation of angiogenesis: a new chapter in cancer biology. Front Oncol. 2021;11: 553706. https:\/\/doi.org\/10.3389\/fonc.2021.553706.","journal-title":"Front Oncol"},{"issue":"3","key":"3018_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86(3):353\u201364. https:\/\/doi.org\/10.1016\/S0092-8674(00)80108-7.","journal-title":"Cell"},{"issue":"9","key":"3018_CR69","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrm3176","volume":"12","author":"SP Herbert","year":"2011","unstructured":"Herbert SP, Stainier DYR. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011;12(9):551\u201364. https:\/\/doi.org\/10.1038\/nrm3176.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3018_CR70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.matbio.2015.03.004","volume":"44\u201346","author":"Y Itoh","year":"2015","unstructured":"Itoh Y. Membrane-type matrix metalloproteinases: their functions and regulations. Matrix Biol. 2015;44\u201346:207\u201323. https:\/\/doi.org\/10.1016\/j.matbio.2015.03.004.","journal-title":"Matrix Biol"},{"issue":"1","key":"3018_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","volume":"328","author":"E Fagiani","year":"2013","unstructured":"Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013;328(1):18\u201326. https:\/\/doi.org\/10.1016\/j.canlet.2012.08.018.","journal-title":"Cancer Lett"},{"issue":"2","key":"3018_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O\u2019Reilly","year":"1994","unstructured":"O\u2019Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell. 1994;79(2):315\u201328. https:\/\/doi.org\/10.1016\/0092-8674(94)90200-3.","journal-title":"Cell"},{"issue":"49","key":"3018_CR73","doi-asserted-by":"publisher","first-page":"11655","DOI":"10.1021\/bi901265z","volume":"48","author":"Y Fu","year":"2009","unstructured":"Fu Y, Chen Y, Luo X, et al. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin. Biochemistry. 2009;48(49):11655\u201363. https:\/\/doi.org\/10.1021\/bi901265z.","journal-title":"Biochemistry"},{"key":"3018_CR74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-019-1125-9","volume":"19","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Wang W, Zhou Q, et al. Roles of circRNAs in the tumour microenvironment. Mol Cancer. 2020;19:14. https:\/\/doi.org\/10.1186\/s12943-019-1125-9.","journal-title":"Mol Cancer"},{"key":"3018_CR75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","volume":"403","author":"Z Zhong","year":"2017","unstructured":"Zhong Z, Huang M, Lv M, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway. Cancer Lett. 2017;403:305\u201317. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.027.","journal-title":"Cancer Lett"},{"issue":"2","key":"3018_CR76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma \u2014 evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157.","journal-title":"Nat Rev Clin Oncol"},{"issue":"S1","key":"3018_CR77","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/liv.14102","volume":"39","author":"L Fouassier","year":"2019","unstructured":"Fouassier L, Marzioni M, Afonso MB, et al. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. Liver Int. 2019;39(S1):43\u201362. https:\/\/doi.org\/10.1111\/liv.14102.","journal-title":"Liver Int"},{"issue":"2","key":"3018_CR78","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/13543784.2022.2034785","volume":"31","author":"C Mayr","year":"2022","unstructured":"Mayr C, Kiesslich T, Modest DP, Stintzing S, Ocker M, Neureiter D. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned? Expert Opin Investig Drugs. 2022;31(2):221\u201333. https:\/\/doi.org\/10.1080\/13543784.2022.2034785.","journal-title":"Expert Opin Investig Drugs"},{"key":"3018_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-020-01180-y","volume":"19","author":"C Cui","year":"2020","unstructured":"Cui C, Yang J, Li X, Liu D, Fu L, Wang X. Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Mol Cancer. 2020;19:58. https:\/\/doi.org\/10.1186\/s12943-020-01180-y.","journal-title":"Mol Cancer"},{"issue":"1","key":"3018_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","volume":"36","author":"V Subbiah","year":"2018","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA, et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600\u2013mutant anaplastic thyroid cancer. J Clin Oncol. 2018;36(1):7\u201313. https:\/\/doi.org\/10.1200\/JCO.2017.73.6785.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3018_CR81","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","volume":"21","author":"GL Beatty","year":"2015","unstructured":"Beatty GL, Gladney WL. Immune escape mechanisms as a guide for cancer immunotherapy. Clin Cancer Res. 2015;21(4):687\u201392. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1860.","journal-title":"Clin Cancer Res"},{"key":"3018_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215853","volume":"546","author":"R Chen","year":"2022","unstructured":"Chen R, Zheng D, Li Q, et al. Immunotherapy of cholangiocarcinoma: therapeutic strategies and predictive biomarkers. Cancer Lett. 2022;546: 215853. https:\/\/doi.org\/10.1016\/j.canlet.2022.215853.","journal-title":"Cancer Lett"},{"issue":"6","key":"3018_CR83","doi-asserted-by":"publisher","first-page":"706","DOI":"10.5858\/arpa.2018-0584-CP","volume":"144","author":"EE Walk","year":"2020","unstructured":"Walk EE, Yohe SL, Beckman A, et al. The cancer immunotherapy biomarker testing landscape. Arch Pathol Lab Med. 2020;144(6):706\u201324. https:\/\/doi.org\/10.5858\/arpa.2018-0584-CP.","journal-title":"Arch Pathol Lab Med"},{"issue":"19","key":"3018_CR84","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","volume":"81","author":"J Ge","year":"2021","unstructured":"Ge J, Wang J, Xiong F, et al. Epstein-Barr virus\u2013encoded circular RNA circBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1. Cancer Res. 2021;81(19):5074\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-4321.","journal-title":"Cancer Res"},{"issue":"5","key":"3018_CR85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10565-021-09613-0","volume":"38","author":"C Gao","year":"2022","unstructured":"Gao C, Xu YJ, Qi L, Bao Y, Zhang L, Zheng L. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124\/PD-L1 axis. Cell Biol Toxicol. 2022;38(5):825\u201345. https:\/\/doi.org\/10.1007\/s10565-021-09613-0.","journal-title":"Cell Biol Toxicol"},{"key":"3018_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00113","volume":"7","author":"K Pant","year":"2020","unstructured":"Pant K, Richard S, Peixoto E, Gradilone SA. Role of glucose metabolism reprogramming in the pathogenesis of cholangiocarcinoma. Front Med. 2020;7: 113. https:\/\/doi.org\/10.3389\/fmed.2020.00113.","journal-title":"Front Med"},{"issue":"5","key":"3018_CR87","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1042\/BST20160094","volume":"44","author":"M Potter","year":"2016","unstructured":"Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44(5):1499\u2013505. https:\/\/doi.org\/10.1042\/BST20160094.","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"3018_CR88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703\u20137. https:\/\/doi.org\/10.1016\/j.cell.2008.08.021.","journal-title":"Cell"},{"key":"3018_CR89","doi-asserted-by":"publisher","DOI":"10.14670\/HH-11-819","author":"U Thonsri","year":"2017","unstructured":"Thonsri U, Seubwai W, Waraasawapati S, Sawanyawisuth K, Vaeteewoottacharn K, Boonmars T, Chaon U. Overexpression of lactate dehydrogenase a in cholangiocarcinoma is correlated with poor prognosis. Histol Histopathol. 2017. https:\/\/doi.org\/10.14670\/HH-11-819.","journal-title":"Histol Histopathol"},{"key":"3018_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1477-7819-12-78","volume":"12","author":"Y Yu","year":"2014","unstructured":"Yu Y, Liao M, Liu R, Chen J, Feng H, Fu Z. Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment. World J Surg Oncol. 2014;12:78. https:\/\/doi.org\/10.1186\/1477-7819-12-78.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"3018_CR91","first-page":"15511","volume":"8","author":"W Cheng","year":"2015","unstructured":"Cheng W, Liu Y, Zuo Z, et al. Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells. Int J Clin Exp Pathol. 2015;8(12):15511\u201326.","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"3018_CR92","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(9):512\u201322. https:\/\/doi.org\/10.1038\/nrgastro.2011.131.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3018_CR93","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.1038\/s41598-017-09740-x","volume":"7","author":"M Sugimoto","year":"2017","unstructured":"Sugimoto M, Takagi T, Konno N, et al. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer. Sci Rep. 2017;7:9198. https:\/\/doi.org\/10.1038\/s41598-017-09740-x.","journal-title":"Sci Rep"},{"issue":"2","key":"3018_CR94","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","volume":"379","author":"H Zhang","year":"2016","unstructured":"Zhang H, Yang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 2016;379(2):198\u2013205. https:\/\/doi.org\/10.1016\/j.canlet.2015.09.008.","journal-title":"Cancer Lett"},{"key":"3018_CR95","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/CMAR.S280307","volume":"13","author":"T Zhang","year":"2021","unstructured":"Zhang T, Li M, Lu H, Peng T. Up-regulation of circEIF6 contributes to pancreatic cancer development through targeting miR-557\/SLC7A11\/PI3K\/AKT signaling. Cancer Manag Res. 2021;13:247\u201358. https:\/\/doi.org\/10.2147\/CMAR.S280307.","journal-title":"Cancer Manag Res"},{"issue":"24","key":"3018_CR96","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1111\/jcmm.16089","volume":"24","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xue C, Cui X, et al. Circ_0075829 facilitates the progression of pancreatic carcinoma by sponging miR-1287-5p and activating LAMTOR3 signalling. J Cell Mol Med. 2020;24(24):14596\u2013607. https:\/\/doi.org\/10.1111\/jcmm.16089.","journal-title":"J Cell Mol Med"},{"key":"3018_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12943-020-01205-6","volume":"19","author":"Y Kong","year":"2020","unstructured":"Kong Y, Li Y, Luo Y, et al. CircNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p\/PIK3R1\/VEGF-C axis in pancreatic cancer. Mol Cancer. 2020;19:82. https:\/\/doi.org\/10.1186\/s12943-020-01205-6.","journal-title":"Mol Cancer"},{"issue":"11","key":"3018_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/genes12111701","volume":"12","author":"S Yu","year":"2021","unstructured":"Yu S, Wang M, Zhang H, Guo X, Qin R. Circ_0092367 inhibits EMT and gemcitabine resistance in pancreatic cancer via regulating the miR-1206\/ESRP1 axis. Genes. 2021;12(11): 1701. https:\/\/doi.org\/10.3390\/genes12111701.","journal-title":"Genes"},{"issue":"8","key":"3018_CR99","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981\u20134. https:\/\/doi.org\/10.1038\/cr.2015.82.","journal-title":"Cell Res"},{"key":"3018_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2018.01.011","volume":"418","author":"B Chen","year":"2018","unstructured":"Chen B, Huang S. Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018;418:41\u201350. https:\/\/doi.org\/10.1016\/j.canlet.2018.01.011.","journal-title":"Cancer Lett"},{"issue":"1","key":"3018_CR101","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","volume":"61","author":"JH Bahn","year":"2015","unstructured":"Bahn JH, Zhang Q, Li F, et al. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2015;61(1):221\u201330. https:\/\/doi.org\/10.1373\/clinchem.2014.230433.","journal-title":"Clin Chem"},{"issue":"4","key":"3018_CR102","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869-881.e13. https:\/\/doi.org\/10.1016\/j.cell.2018.12.021.","journal-title":"Cell"},{"issue":"4","key":"3018_CR103","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular rnas in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319\u201336. https:\/\/doi.org\/10.1016\/j.trecan.2020.01.012.","journal-title":"Trends Cancer"},{"issue":"6","key":"3018_CR104","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1159\/000491624","volume":"47","author":"SY Zhao","year":"2018","unstructured":"Zhao SY, Wang J, Ouyang SB, Huang ZK, Liao L. Salivary circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as novel biomarkers for the diagnosis of oral squamous cell carcinoma. Cell Physiol Biochem. 2018;47(6):2511\u201321. https:\/\/doi.org\/10.1159\/000491624.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"3018_CR105","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10528-021-10084-5","volume":"60","author":"ZL Jiang","year":"2022","unstructured":"Jiang ZL, Zhang FX, Zhan HL, et al. MiR-181b-5p promotes the progression of cholangiocarcinoma by targeting PARK2 via PTEN\/PI3K\/AKT signaling pathway. Biochem Genet. 2022;60(1):223\u201340. https:\/\/doi.org\/10.1007\/s10528-021-10084-5.","journal-title":"Biochem Genet"},{"issue":"3\u20134","key":"3018_CR106","doi-asserted-by":"publisher","first-page":"CBM-240119","DOI":"10.1101\/2024.11.15.623822","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark. 2024;41(3\u20134):CBM-240119. https:\/\/doi.org\/10.1101\/2024.11.15.623822.","journal-title":"Cancer Biomark"},{"key":"3018_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12: 952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290.","journal-title":"Front Oncol"},{"issue":"8","key":"3018_CR108","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J Cancer Res"},{"key":"3018_CR109","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103. https:\/\/doi.org\/10.1016\/j.cancergen.2023.10.001.","journal-title":"Cancer Genet"},{"key":"3018_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0747-x","volume":"37","author":"Y Xu","year":"2018","unstructured":"Xu Y, Yao Y, Jiang X, et al. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2\/LSD1\/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J Exp Clin Cancer Res. 2018;37: 81. https:\/\/doi.org\/10.1186\/s13046-018-0747-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"3018_CR111","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cancergen.2024.05.001","volume":"284","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Wu J, Liu X, Li L, Zhang J. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the miR-185\u20135p\/PLOD1\/Akt\/mTOR pathway. Cancer Genet. 2024;284:48\u201357. https:\/\/doi.org\/10.1016\/j.cancergen.2024.05.001.","journal-title":"Cancer Genet"},{"key":"3018_CR112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-025-01716-z","volume":"18","author":"C Liu","year":"2025","unstructured":"Liu C, Wang X, Liu E, et al. Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution. J Hematol Oncol. 2025;18:66. https:\/\/doi.org\/10.1186\/s13045-025-01716-z.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"3018_CR113","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"3018_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/cso2.1051","volume":"3","author":"N Chatterjee","year":"2023","unstructured":"Chatterjee N, Pulipaka B, Subbalakshmi AR, Jolly MK, Nair R. Unraveling the dangerous duet between cancer cell plasticity and drug resistance. Comput Syst Oncol. 2023;3(3): e1051. https:\/\/doi.org\/10.1002\/cso2.1051.","journal-title":"Comput Syst Oncol"},{"key":"3018_CR115","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2024.09.001","volume":"288\u2013289","author":"L Jahangiri","year":"2024","unstructured":"Jahangiri L. Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment. Cancer Genet. 2024;288\u2013289:32\u20139. https:\/\/doi.org\/10.1016\/j.cancergen.2024.09.001.","journal-title":"Cancer Genet"},{"issue":"1","key":"3018_CR116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41392-024-01814-3","volume":"9","author":"N Wen","year":"2024","unstructured":"Wen N, Peng D, Xiong X, et al. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring. Signal Transduct Target Ther. 2024;9(1):107. https:\/\/doi.org\/10.1038\/s41392-024-01814-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"13_Supplement","key":"3018_CR117","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/1538-7445.AM2018-2162","volume":"78","author":"R Li","year":"2018","unstructured":"Li R, Huang Y, Liu H, Dilger JP, Lin J. Abstract 2162: comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis. Cancer Res. 2018;78(13_Supplement):2162\u20132162. https:\/\/doi.org\/10.1158\/1538-7445.AM2018-2162.","journal-title":"Cancer Res"},{"issue":"562","key":"3018_CR118","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay0152","volume":"12","author":"TY Jiang","year":"2020","unstructured":"Jiang TY, Pan YF, Wan ZH, et al. Pten status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma. Sci Transl Med. 2020;12(562): eaay0152. https:\/\/doi.org\/10.1126\/scitranslmed.aay0152.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3018_CR119","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11427-022-2171-2","volume":"66","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhang B. RNA therapeutics: updates and future potential. Sci China Life Sci. 2023;66(1):12\u201330. https:\/\/doi.org\/10.1007\/s11427-022-2171-2.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"3018_CR120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0034-1397346","volume":"35","author":"SA Gradilone","year":"2015","unstructured":"Gradilone SA, O\u2019Hara SP, Masyuk TV, Pisarello MJL, LaRusso NF. MicroRNAs and benign biliary tract diseases. Semin Liver Dis. 2015;35(1):26\u201335. https:\/\/doi.org\/10.1055\/s-0034-1397346.","journal-title":"Semin Liver Dis"},{"key":"3018_CR121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.004.","journal-title":"Cancer Lett"},{"key":"3018_CR122","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/s41467-021-24975-z","volume":"12","author":"K Rahimi","year":"2021","unstructured":"Rahimi K, Ven\u00f8 MT, Dupont DM, Kjems J. Nanopore sequencing of brain-derived full-length circRNAs reveals circRNA-specific exon usage, intron retention and microexons. Nat Commun. 2021;12:4825. https:\/\/doi.org\/10.1038\/s41467-021-24975-z.","journal-title":"Nat Commun"},{"issue":"2","key":"3018_CR123","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/hep.28925","volume":"65","author":"SA Gradilone","year":"2017","unstructured":"Gradilone SA. Extracellular vesicles as therapeutic carriers of MicroRNAs for cholangiocarcinoma. Hepatology. 2017;65(2):404\u20136. https:\/\/doi.org\/10.1002\/hep.28925.","journal-title":"Hepatology"},{"issue":"2","key":"3018_CR124","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03018-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03018-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03018-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:17:01Z","timestamp":1758093421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03018-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":124,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3018"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03018-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review paper. No ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"455"}}